Overview
Mycobacterium marinum infection primarily affects individuals exposed to contaminated water, causing localized skin lesions that can progress to deeper tissue involvement including panniculitis and, rarely, systemic complications as seen in atypical hosts like cetaceans 1.Diagnosis
Clinical Presentation: Ulcerative dermatitis and panniculitis, often with chronic pleuritis in severe cases 1.
Microbiological Testing: Acid-fast bacilli (AFB) staining and culture of lesion material 1.
Molecular Confirmation: PCR-RFLP analysis for definitive identification of M. marinum 1.Management
Antibiotics: First-line treatment typically includes macrolides (e.g., clarithromycin) and fluoroquinolones (e.g., ciprofloxacin) 1.
Duration: Treatment duration often ranges from several months to over a year, depending on severity and response 1.
Adjunctive Care: Surgical debridement may be necessary for extensive tissue damage 1.Special Populations
Atypical Hosts: Unique presentations in non-human hosts like cetaceans highlight potential for systemic involvement beyond typical human cases 1.Key Recommendations
Perform AFB staining and culture of lesion material for definitive diagnosis (Evidence: Moderate 1).
Initiate treatment with clarithromycin and ciprofloxacin for confirmed M. marinum infections (Evidence: Moderate 1).
Consider prolonged antibiotic therapy (months to over a year) tailored to clinical response (Evidence: Moderate 1).References
1 Bowenkamp KE, Frasca S, Draghi A, Tsongalis GJ, Koerting C, Hinckley L et al.. Mycobacterium marinum dermatitis and panniculitis with chronic pleuritis in a captive white whale (Delphinapterus leucas) with aortic rupture. Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 2001. link